Necroptosis mediated by FKBP5 in alveolar fibroblasts drives Pseudomonas aeruginosa-induced acute lung injury
International Immunopharmacology · 2026-04 · 174 · 116368
DOI: 10.1016/j.intimp.2026.116368 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-04. Verfasst von Dong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China. Hauptthemen laut MEDLINE: Tacrolimus Binding Proteins, Acute Lung Injury, Fibroblasts, Necroptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Science and Technology Major Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Pseudomonas aeruginosa (PA) is a leading cause of nosocomial infections and is frequently associated with severe dysregulation of the pulmonary inflammatory microenvironment. Alveolar fibroblasts can regulate the inflammatory microenvironment, but their specific role in PA-induced lung injury remains elusive. Using single-cell RNA sequencing, we identified a pro-inflammatory phenotype in fibroblasts during PA-induced acute lung injury, which was associated with high expression of the inflammatory target FK506 binding protein 51 (FKBP5). FKBP5 deficiency markedly alleviated inflammation and pulmonary edema in Fkbp5-/- mice with bacterial lung injury. Consistently, single-cell RNA sequencing revealed that FKBP5 deficiency attenuated the pro-inflammatory phenotype of fibroblasts. Furthermore, alveolar fibroblast-specific conditional knockout of FKBP5 confirmed the critical contribution of FKBP5 in these cells to PA-induced inflammatory injury. Mechanistically, FKBP5 promoted necroptosis in alveolar fibroblasts, thereby activating NF-κB signaling, and driving neutrophil recruitment and activation, which collectively exacerbated lung injury. These findings identify FKBP5-mediated necroptosis in alveolar fibroblasts as a central mechanism of PA-associated acute lung injury and suggest FKBP5 as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, Binzhou Medical University Hospital, Binzhou, Shandong, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Jinan, Sh…
- Department of Cardiovascular Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Förderung
- China Postdoctoral Science Foundation
- National Science and Technology Major Project
- National Natural Science Foundation of China
- Science and Technology Development Plan of Shandong Province
- Shandong Provincial Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, D., Qu, Y., Han, Y., Liu, W., Wang, X., Wang, T., & Qi, Q. (2026). Necroptosis mediated by FKBP5 in alveolar fibroblasts drives Pseudomonas aeruginosa-induced acute lung injury. International Immunopharmacology, 174, 116368. https://doi.org/10.1016/j.intimp.2026.116368
Vancouver
Zhang D, Qu Y, Han Y, Liu W, Wang X, Wang T, et al. Necroptosis mediated by FKBP5 in alveolar fibroblasts drives Pseudomonas aeruginosa-induced acute lung injury. International Immunopharmacology. 2026;174:116368. doi:10.1016/j.intimp.2026.116368
BibTeX
@article{Zhang2026,
author = {Zhang, Dong and Qu, Yinghui and Han, Yuexin and Liu, Wei and Wang, Xiaozhi and Wang, Tao and Qi, Qian},
title = {Necroptosis mediated by FKBP5 in alveolar fibroblasts drives Pseudomonas aeruginosa-induced acute lung injury},
journal = {International Immunopharmacology},
year = {2026},
volume = {174},
pages = {116368},
doi = {10.1016/j.intimp.2026.116368}
}
EUVIMED